In this Section |
213258 Overview of State Initiatives Advancing Evidence-Based Prescribing and Reducing Conflicts of Interest in Medical CareTuesday, November 10, 2009: 12:55 PM
States are at the forefront of efforts to limit pharmaceutical and medical device industry financial influence on prescribing and medical care. Legislation enacted in the states includes prescriber education programs, disclosure of industry payments and gifts to prescribers, gift bans, licensing and regulation of industry sales detailers, limiting the use of prescriber data for marketing purposes, and marketing to children. This presentation will present an overview of these state initiatives and emerging trends in the states.
Learning Objectives:
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I am Executive Director of an organization of state legislators developing policy on prescription drug issues. In this capacity I testify at public hearings both at the state and federal levels and present on pharmaceutical issues at conferences, and provide technical assistance to legislators in developing policy. I am myself a state legislator and have sponsored legislation on prescription drug pricing, marketing, and access. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
See more of: Evidence Based Prescribing and Conflicts of Interest in Drug Policy & Pharmacy Services
See more of: Medical Care |